Different Tyrosine Kinase Inhibitors Used in Treating EGFR-Mutant Pulmonary Adenocarcinoma with Brain Metastasis and Intracranial Intervention Have No Impact on Clinical Outcomes

SIMPLE SUMMARY: Brain metastasis is a factor of a poor prognosis in patients with non-small-cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutations. The standard treatment is systemic therapy combined with intracranial intervention, such as craniotomy or radiotherapy. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Chia-Yu, Tsai, Ming-Ju, Hung, Jen-Yu, Wu, Kuan-Li, Tsai, Ying-Ming, Tsai, Yu-Chen, Chuang, Cheng-Hao, Lee, Tai-Huang, Chen, Huang-Chi, Yang, Chih-Jen, Chong, Inn-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818223/
https://www.ncbi.nlm.nih.gov/pubmed/36612183
http://dx.doi.org/10.3390/cancers15010187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818223/
https://www.ncbi.nlm.nih.gov/pubmed/36612183
http://dx.doi.org/10.3390/cancers15010187

Ejemplares similares